Clinical benefit of adding radiation for immune checkpoint inhibitor-refractory Merkel cell carcinoma: A 27-patient analysis

Key Points

• Radiation therapy improves tumor response in patients with Merkel cell carcinoma that has resisted immune checkpoint inhibitors, indicating a new avenue for care.
• The clinical outcomes show that 27 patients benefited from the combined treatment approach, revealing promising results.
• Observational analysis involved assessing clinical outcomes after radiation was added to traditional immune checkpoint inhibitor therapy.
• Highlights a potential shift in treatment for difficult-to-treat Merkel cell carcinoma cases, needing further validation.